Acute Renal Failure due to a Tobramycin and Vancomycin Spacer in Revision Two-Staged Knee Arthroplasty.
Ronak A PatelHayden P BakerSara B SmithPublished in: Case reports in nephrology (2018)
Two-stage revision total knee arthroplasty (TKA) is the standard of care for prosthetic joint infections. The first stage involves removal of the infected prosthesis and placement of an antibiotic impregnated cement spacer; following a period ranging from 4 weeks to 6 months, the spacer is then removed and replaced with a permanent prosthesis. The advantage to this approach is that antibiotic impregnated spacers provide supratherapeutic levels in the joint without toxic accumulation in serum. However, it remains important for physicians and pharmacists to be aware of antibiotic associated complications in knee revisions. We present a case of a two-stage revision total knee arthroplasty in which a cement antibiotic spacer caused acute renal failure and ultimately resulted in persistent chronic kidney disease without hemodialysis at 2 months' follow-up. Our case reports the third highest serum tobramycin (13.7 mcg/ml) and second highest serum creatinine (8.62 mg/dl) for patients experiencing ARF due to an antibiotic spacer in two-stage revision TKA.
Keyphrases
- total knee arthroplasty
- end stage renal disease
- chronic kidney disease
- total hip
- peritoneal dialysis
- liver failure
- healthcare
- respiratory failure
- ejection fraction
- primary care
- newly diagnosed
- palliative care
- methicillin resistant staphylococcus aureus
- prognostic factors
- metabolic syndrome
- chronic pain
- uric acid
- patient reported outcomes
- total hip arthroplasty
- general practice
- ultrasound guided
- quality improvement
- preterm birth
- knee osteoarthritis
- affordable care act